Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: An observational study of correlation with ethnicity, histological subtype and outcome in a UK population

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Robinson, Max ^a   Suh, Yae Eun ^b   Paleri, Vinidh ^c   Devlin, Debbie ^d   Ayaz, Bushra ^d   Pertl, Laura ^d   Thavaraj, Selvam ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Epstein Barr virus; Human papillomavirus; Nasopharyngeal carcinoma

Indexed keywords

PROTEIN P16; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; EPSTEIN BARR VIRUS INFECTION; ETHNICITY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NASOPHARYNX CARCINOMA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SCREENING TEST; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA; UNITED KINGDOM;

EID: 84883120259     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-30     Document Type: Article

References (27)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. Cancer incidence in five continents. Comparability and quality of data. Parkin DM, Muir CS, IARC Sci Publ 1992 120 45 173 1284606
3. The enigmatic epidemiology of nasopharyngeal carcinoma. Chang ET, Adami HO, Cancer Epidemiol Biomarkers Prev 2006 15 1765 1777 10.1158/1055-9965.EPI-06- 0353 17035381 (Pubitemid 44664247)
4. Price G, Roche M, Crowther R, Wright R, Profiles of Head and Neck Cancers in England: Incidence, Mortality and Survival http://www.ncin.org.uk/ publications/reports/
5. Barnes L, Pathology and genetics of head and neck tumours Lyon: IARC Press 2005
6. Nasopharyngeal carcinoma. Wei WI, Sham JS, Lancet 2005 365 2041 2054 10.1016/S0140-6736(05)66698-6 15950718 (Pubitemid 40812341)
7. Detection of Epstein-Barr virus and human papillomavirus in nasopharyngeal carcinoma by the polymerase chain reaction technique. Giannoudis A, Ergazaki M, Segas J, Giotakis J, Adamopoulos G, Gorgoulis V, Spandidos DA, Cancer Lett 1995 89 177 181 10.1016/0304-3835(94)03667-8 7889526
8. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Rassekh CH, Rady PL, Arany I, Tyring SK, Knudsen S, Calhoun KH, Seikaly H, Bailey BJ, Laryngoscope 1998 108 362 367 10.1097/00005537-199803000-00010 9504608 (Pubitemid 28136643)
9. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Punwaney R, Brandwein MS, Zhang DY, Urken ML, Cheng R, Park CS, Li HB, Li X, Head Neck 1999 21 21 29 10.1002/(SICI)1097-0347(199901)21:1<21::AID-HED3>3.0.CO;2-Z 9890347 (Pubitemid 29006452)
10. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization. Mirzamani N, Salehian P, Farhadi M, Tehran EA, Exp Mol Pathol 2006 81 231 234 10.1016/j.yexmp.2006.04.006 16787643 (Pubitemid 44665861)
11. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Maxwell JH, Kumar B, Feng FY, McHugh JB, Cordell KG, Eisbruch A, Worden FP, Wolf GT, Prince ME, Moyer JS, et al. Head Neck 2010 32 562 567 19757421
12. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Lo EJ, Bell D, Woo JS, Li G, Hanna EY, El-Naggar AK, Sturgis EM, Laryngoscope 2010 120 1990 1997 10.1002/lary.21089 20824783
13. Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma. Laantri N, Attaleb M, Kandil M, Naji F, Mouttaki T, Dardari R, Belghmi K, Benchakroun N, El Mzibri M, Khyatti M, Infect Agent Cancer 2011 6 3 10.1186/1750-9378-6-3 21352537
14. High-risk human papillomavirus in nasopharyngeal carcinoma. Singhi AD, Califano J, Westra WH, Head Neck 2012 34 213 218 10.1002/hed.21714 21484924
15. Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread. Shah SM, Drage MG, Lichtman AH, Haddad RI, J Clin Oncol 2012 30 321 323 10.1200/JCO.2012.42.3566 23008310
16. Human papillomavirus 16 detected in nasopharyngeal carcinomas in Caucasian Americans but not in endemic Southern Chinese patients. Lin Z, Khong B, Kwok S, Cao H, West RB, Le QT, Kong CS, Head Neck 2013 Epud ahead of print 10.1002/hed.23362
17. Epidemiology and clinical aspects of HPV in head and neck cancers. Chaturvedi AK, Head Neck Pathol 2012 6 Suppl 1 16 24 22782220
18. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML, Am J Surg Pathol 2012 36 945 954 10.1097/PAS.0b013e318253a2d1 22743284
19. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M, Head Neck Pathol 2012 6 Suppl 1 104 120 22782230
20. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH, Int J Cancer 2007 121 2465 2472 10.1002/ijc.22980 17680565 (Pubitemid 350022416)
21. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. Thavaraj S, Stokes A, Guerra E, Bible J, Halligan E, Long A, Okpokam A, Sloan P, Odell E, Robinson M, J Clin Pathol 2011 64 308 312 10.1136/jcp.2010.088450 21345874
22. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, et al. Clin Cancer Res 2011 17 6262 6271 10.1158/1078-0432.CCR-11-0388 21969383
23. Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus. Lopes V, Murray P, Williams H, Woodman C, Watkinson J, Robinson M, Oral Oncol 2011 47 698 701 10.1016/j.oraloncology.2011.04.022 21689967
24. Carlson D, Barnes L, Chan J, Ellis G, Harrison L, Hunt J, Richardson M, Seethala R, Shah J, Thompson LDR, et al. Protocol for the Examination of Specimens From Patients With Carcinomas of the Pharynx http://www.cap.org/apps/ docs/committees/cancer/cancer-protocols/2012/Pharynx-12protocol.pdf
25. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA, Science 1988 239 487 491 10.1126/science.2448875 2448875 (Pubitemid 18084310)
26. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM, J Clin Microbiol 1997 35 791 795 9041439 (Pubitemid 27083888)
27. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. White JS, Weissfeld JL, Ragin CC, Rossie KM, Martin CL, Shuster M, Ishwad CS, Law JC, Myers EN, Johnson JT, Gollin SM, Oral Oncol 2007 43 701 712 10.1016/j. oraloncology.2006.09.001 17112776 (Pubitemid 47058372)